Revenue growth accelerated to 8.8% YoY in 2026Q2, with gross margin expanding to 40.7% and operating income surging 43.4% YoY, though net income includes significant investment gains that may overstate core profitability.
National HealthCare Corporation (NHC) annual income statement — 30-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Sales/Revenue | 1.58B | 1.52B | 1.3B | 1.14B | 1.07B | 1.01B | 980.71M | 996.38M | 980.35M | 963.89M | 923.58M | 906.62M | 871.68M | 788.96M | 761M | 773.24M | 720.65M | 668.22M | 633.21M | 598.03M | 562.96M | 542.38M | 521.83M | 472.86M | 458.25M | 419.97M | 462.42M | 440.14M | 441.2M | 463.48M | 386.3M |
| Revenue Growth % | 5.58% | 16.94% | 13.7% | 6.26% | 6.27% | 3.08% | -1.57% | 1.64% | 1.71% | 4.37% | 1.87% | 4.01% | 10.49% | 3.67% | -1.58% | 7.3% | 7.85% | 5.53% | 5.88% | 6.23% | 3.79% | 3.94% | 10.36% | 3.19% | 9.12% | -9.18% | 5.06% | -0.24% | -4.81% | 19.98% | 10.56% |
| Cost of Goods Sold | 1.08B | 921.08M | 810.93M | 712.34M | 686.17M | 666.06M | 609.31M | 592.83M | 582.72M | 572.04M | 548.01M | 532.74M | 510.25M | 453.56M | 426.93M | 428.67M | 400.27M | 558.85M | 538.51M | 502.09M | 157.66M | 150.16M | 149.56M | 129.72M | 127.05M | 111.72M | 119.59M | 121.35M | 163.5M | 140M | 123.3M |
| COGS % of Revenue | - | 60.69% | 62.48% | 62.4% | 63.87% | 65.89% | 62.13% | 59.5% | 59.44% | 59.35% | 59.34% | 58.76% | 58.54% | 57.49% | 56.1% | 55.44% | 55.54% | 83.63% | 85.05% | 83.96% | 28.01% | 27.69% | 28.66% | 27.43% | 27.72% | 26.6% | 25.86% | 27.57% | 37.06% | 30.21% | 31.92% |
| Gross Profit | 506.77M | 596.7M | 487.01M | 429.2M | 388.11M | 344.88M | 371.41M | 403.55M | 397.63M | 391.85M | 375.57M | 373.89M | 361.43M | 335.4M | 334.07M | 344.57M | 320.38M | 109.37M | 94.7M | 95.94M | 405.29M | 392.22M | 372.27M | 343.15M | 331.21M | 308.25M | 342.83M | 318.8M | 277.7M | 323.48M | 263M |
| Gross Margin % | 31.99% | 39.31% | 37.52% | 37.6% | 36.13% | 34.11% | 37.87% | 40.5% | 40.56% | 40.65% | 40.66% | 41.24% | 41.46% | 42.51% | 43.9% | 44.56% | 44.46% | 16.37% | 14.95% | 16.04% | 71.99% | 72.31% | 71.34% | 72.57% | 72.28% | 73.4% | 74.14% | 72.43% | 62.94% | 69.79% | 68.08% |
| Gross Profit Growth % | - | 22.52% | 13.47% | 10.59% | 12.54% | -7.14% | -7.97% | 1.49% | 1.47% | 4.33% | 0.45% | 3.45% | 7.76% | 0.4% | -3.05% | 7.55% | 192.94% | 15.49% | -1.3% | -76.33% | 3.33% | 5.36% | 8.49% | 3.61% | 7.45% | -10.09% | 7.54% | 14.8% | -14.15% | 23% | 8.5% |
| Operating Expenses | 351.84M | 468.35M | 401.25M | 372.07M | 356.22M | 293.95M | 323.25M | 354.51M | 341.55M | 337.74M | 315.03M | 306.76M | 293.42M | 263.32M | 265.83M | 265.72M | 262.76M | 58.5M | 57.14M | 57.21M | 357.34M | 343M | 330.91M | 307.78M | 292.32M | 280.93M | 318.79M | 299.41M | 255.4M | 273.3M | 222.8M |
| OpEx % of Revenue | - | 30.86% | 30.91% | 32.59% | 33.16% | 29.08% | 32.96% | 35.58% | 34.84% | 35.04% | 34.11% | 33.84% | 33.66% | 33.38% | 34.93% | 34.36% | 36.46% | 8.75% | 9.02% | 9.57% | 63.48% | 63.24% | 63.41% | 65.09% | 63.79% | 66.89% | 68.94% | 68.02% | 57.89% | 58.97% | 57.68% |
| Selling, General & Admin | 35.37M | 46.23M | 43.18M | 41.52M | 40.98M | 40.82M | 40.49M | 40.52M | 40.92M | 40.37M | 41.29M | 39.97M | 39.73M | 39.45M | 39.35M | 39.74M | 38.09M | 32.35M | 31.45M | 40.2M | 343.17M | 327.54M | 317.15M | 295.4M | 279.95M | 268.2M | 304.35M | 289.02M | 243.3M | 258.3M | 209.6M |
| SG&A % of Revenue | - | 3.05% | 3.33% | 3.64% | 3.81% | 4.04% | 4.13% | 4.07% | 4.17% | 4.19% | 4.47% | 4.41% | 4.56% | 5% | 5.17% | 5.14% | 5.28% | 4.84% | 4.97% | 6.72% | 60.96% | 60.39% | 60.78% | 62.47% | 61.09% | 63.86% | 65.82% | 65.67% | 55.15% | 55.73% | 54.26% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 3M | 422.12M | 358.06M | 330.54M | 315.24M | 253.14M | 282.76M | 314M | 300.63M | 297.38M | 273.74M | 266.79M | 253.69M | 223.87M | 226.48M | 225.98M | 224.67M | 26.14M | 25.69M | 17.01M | 14.17M | 15.46M | 13.77M | 12.38M | 12.37M | 12.73M | 14.44M | 10.38M | 12.1M | 15M | 13.2M |
| Operating Income | 154.94M | 128.35M | 85.76M | 57.13M | 31.9M | 50.92M | 48.16M | 49.04M | 56.08M | 54.11M | 60.54M | 67.13M | 68.01M | 72.08M | 68.24M | 78.85M | 57.63M | 50.87M | 37.55M | 38.73M | 47.95M | 49.22M | 41.35M | 35.37M | 38.89M | 27.32M | 24.04M | 19.39M | 22.3M | 50.18M | 40.2M |
| Operating Margin % | 9.78% | 8.46% | 6.61% | 5% | 2.97% | 5.04% | 4.91% | 4.92% | 5.72% | 5.61% | 6.56% | 7.4% | 7.8% | 9.14% | 8.97% | 10.2% | 8% | 7.61% | 5.93% | 6.48% | 8.52% | 9.07% | 7.92% | 7.48% | 8.49% | 6.5% | 5.2% | 4.4% | 5.05% | 10.83% | 10.41% |
| Operating Income Growth % | - | 49.66% | 50.1% | 79.13% | -37.37% | 5.75% | -1.8% | -12.55% | 3.63% | -10.62% | -9.81% | -1.3% | -5.65% | 5.63% | -13.46% | 36.83% | 13.28% | 35.47% | -3.03% | -19.23% | -2.58% | 19.02% | 16.93% | -9.05% | 42.35% | 13.64% | 23.99% | -13.06% | -55.56% | 24.82% | 5.79% |
| EBITDA | 204.07M | 173.27M | 127.75M | 99.17M | 72.39M | 91.6M | 90.17M | 91.46M | 97.97M | 96.76M | 99.56M | 104.24M | 102.39M | 100.63M | 98.03M | 107.75M | 84.77M | 76.3M | 62.37M | 55.73M | 60.66M | 63.37M | 53.79M | 46.57M | 50.03M | 39.18M | 38.48M | 29.77M | 34.4M | 65.18M | 53.4M |
| EBITDA Margin % | 12.88% | 11.42% | 9.84% | 8.69% | 6.74% | 9.06% | 9.19% | 9.18% | 9.99% | 10.04% | 10.78% | 11.5% | 11.75% | 12.75% | 12.88% | 13.94% | 11.76% | 11.42% | 9.85% | 9.32% | 10.78% | 11.68% | 10.31% | 9.85% | 10.92% | 9.33% | 8.32% | 6.76% | 7.8% | 14.06% | 13.82% |
| EBITDA Growth % | 22.64% | 35.64% | 28.82% | 37% | -20.97% | 1.58% | -1.4% | -6.65% | 1.25% | -2.82% | -4.48% | 1.8% | 1.76% | 2.65% | -9.02% | 27.11% | 11.1% | 22.34% | 11.9% | -8.12% | -4.27% | 17.81% | 15.49% | -6.92% | 27.69% | 1.82% | 29.25% | -13.45% | -47.22% | 22.05% | 0% |
| D&A (Non-Cash Add-back) | 49.13M | 44.92M | 41.98M | 42.03M | 40.49M | 40.67M | 42.02M | 42.42M | 41.89M | 42.65M | 39.02M | 37.11M | 34.38M | 28.55M | 29.79M | 28.9M | 27.14M | 25.43M | 24.82M | 17.01M | 12.71M | 14.15M | 12.44M | 11.21M | 11.15M | 11.87M | 14.44M | 10.38M | 12.1M | 15M | 13.2M |
| EBIT | 158.72M | 168.8M | 140.54M | 89.06M | 27.79M | 150.88M | 53.82M | 91.15M | 79.58M | 79.44M | 84.15M | 87.88M | 87.36M | 102.51M | 93.94M | 99.83M | 81.48M | 68.37M | 54.16M | 73.41M | 47.95M | 49.22M | 41.35M | 35.37M | 38.89M | 27.32M | 24.04M | 19.39M | 22.3M | 50.18M | 40.2M |
| Net Interest Income | 508K | 3.47M | 5.97M | 8.06M | 4.57M | 3.82M | 4.4M | 4.05M | 2.49M | 1.28M | 1.54M | 2.89M | 2.38M | 4.91M | 4.17M | 4.54M | 4.87M | -716K | -873K | -1.17M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 8.6M | 9.84M | 10.1M | 8.38M | 5.13M | 4.67M | 5.79M | 7.19M | 7.18M | 6.17M | 5.48M | 5.49M | 4.55M | 5.24M | 4.62M | 4.98M | 5.38M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 8.09M | 6.37M | 4.13M | 324K | 563K | 845K | 1.4M | 3.13M | 4.7M | 4.89M | 3.94M | 2.61M | 2.17M | 331K | 455K | 443K | 513K | 716K | 873K | 1.17M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -4.3M | 34.08M | 50.65M | 31.6M | -4.67M | 99.11M | 4.27M | 38.98M | 18.81M | 20.44M | 19.66M | 18.15M | 17.18M | 30.09M | 25.25M | 20.53M | 23.34M | 16.78M | 15.73M | 33.51M | 6.33M | -2.53M | -1.3M | -2.08M | -11.44M | -5.16M | -6.88M | -5.35M | -32.4M | -12.98M | -40.2M |
| Pretax Income | 150.64M | 162.43M | 136.41M | 88.74M | 27.23M | 150.04M | 52.42M | 88.02M | 74.88M | 74.55M | 80.21M | 85.27M | 85.19M | 102.18M | 93.48M | 99.38M | 80.97M | 67.66M | 53.29M | 72.23M | 54.28M | 46.69M | 40.05M | 33.29M | 27.45M | 22.16M | 17.16M | 14.04M | -10.1M | 37.2M | 0 |
| Pretax Margin % | 9.51% | 10.7% | 10.51% | 7.77% | 2.53% | 14.84% | 5.35% | 8.83% | 7.64% | 7.73% | 8.68% | 9.41% | 9.77% | 12.95% | 12.28% | 12.85% | 11.24% | 10.12% | 8.42% | 12.08% | 9.64% | 8.61% | 7.68% | 7.04% | 5.99% | 5.28% | 3.71% | 3.19% | -2.29% | 8.03% | - |
| Income Tax | 34.62M | 39.83M | 34.32M | 23.45M | 7.25M | 10.95M | 10.43M | 20.04M | 16.18M | 18.87M | 29.67M | 32.13M | 31.82M | 37.56M | 34.18M | 34.39M | 28.27M | 27.61M | 16.92M | 26.79M | 17.54M | 18.05M | 16.08M | 13.34M | 11.01M | 8.96M | 6.94M | 5.65M | -3.7M | 200K | 0 |
| Effective Tax Rate % | 22.98% | 24.52% | 25.16% | 26.43% | 26.64% | 7.3% | 19.9% | 22.77% | 21.61% | 25.31% | 36.99% | 37.68% | 37.36% | 36.76% | 36.56% | 34.61% | 34.92% | 40.8% | 31.75% | 37.08% | 32.31% | 38.67% | 40.15% | 40.06% | 40.11% | 40.44% | 40.45% | 40.27% | 36.63% | 0.54% | - |
| Net Income | 114.66M | 120.02M | 101.93M | 66.8M | 22.45M | 138.59M | 41.87M | 68.21M | 58.96M | 56.2M | 50.54M | 53.14M | 53.37M | 64.61M | 59.3M | 64.99M | 52.7M | 40.05M | 36.37M | 45.45M | 36.74M | 28.64M | 23.97M | 19.95M | 16.44M | 13.2M | 10.22M | 8.38M | -6.4M | 37M | 29.3M |
| Net Margin % | 7.24% | 7.91% | 7.85% | 5.85% | 2.09% | 13.71% | 4.27% | 6.85% | 6.01% | 5.83% | 5.47% | 5.86% | 6.12% | 8.19% | 7.79% | 8.4% | 7.31% | 5.99% | 5.74% | 7.6% | 6.53% | 5.28% | 4.59% | 4.22% | 3.59% | 3.14% | 2.21% | 1.9% | -1.45% | 7.98% | 7.58% |
| Net Income Growth % | 13.25% | 17.75% | 52.59% | 197.61% | -83.8% | 230.99% | -38.62% | 15.68% | 4.91% | 11.21% | -4.9% | -0.42% | -17.4% | 8.96% | -8.76% | 23.33% | 31.58% | 10.11% | -19.97% | 23.7% | 28.3% | 19.45% | 20.15% | 21.38% | 24.52% | 29.18% | 21.89% | 230.98% | -117.3% | 26.28% | 38.86% |
| Net Income (Continuing) | 116.02M | 122.61M | 102.09M | 65.29M | 19.98M | 139.09M | 41.99M | 67.98M | 58.7M | 55.68M | 50.54M | 53.14M | 53.37M | 64.61M | 59.3M | 64.99M | 52.7M | 40.05M | 36.37M | 45.45M | 36.74M | 28.64M | 23.97M | 19.95M | 16.44M | 13.2M | 10.22M | 8.38M | -6.4M | 37M | 29.3M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 6.3M | 5.74M | 3M | 1.73M | 3.24M | 5.46M | 3.08M | 476K | 1.18M | 694K | -40.02M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.19M | 874K | 812K | 750K | 0 | 0 | 0 | 700K | 800K | 800K |
| EPS (Diluted) | 7.18 | 7.67 | 6.53 | 4.34 | 1.45 | 8.99 | 2.72 | 4.44 | 3.87 | 3.69 | 3.32 | 3.20 | 3.14 | 3.87 | 3.57 | 3.96 | 3.22 | 2.31 | 2.11 | 3.36 | 2.85 | 0.24 | 1.95 | 1.65 | 1.37 | 1.13 | 0.89 | 0.73 | -0.58 | 3.58 | 2.97 |
| EPS Growth % | 11.73% | 17.46% | 50.46% | 199.31% | -83.87% | 230.51% | -38.74% | 14.73% | 4.88% | 11.14% | 3.75% | 1.91% | -18.86% | 8.4% | -9.85% | 22.98% | 39.39% | 9.48% | -37.2% | 17.89% | 1087.5% | -87.69% | 18.18% | 20.44% | 21.24% | 26.97% | 21.92% | 225.86% | -116.2% | 20.54% | 28.02% |
| EPS (Basic) | - | 7.76 | 6.62 | 4.36 | 1.46 | 9.03 | 2.74 | 4.47 | 3.87 | 3.70 | 3.34 | 3.34 | 3.24 | 4.05 | 3.65 | 4.09 | 3.22 | 2.31 | 2.16 | 3.47 | 2.99 | 0.34 | 2.05 | 1.72 | 1.43 | 1.17 | 0.89 | 0.73 | -0.58 | 4.17 | 3.48 |
| Diluted Shares Outstanding | 15.96M | 15.65M | 15.6M | 15.38M | 15.45M | 15.42M | 15.37M | 15.36M | 15.24M | 15.22M | 15.21M | 14.49M | 14.22M | 16.7M | 16.6M | 16.41M | 13.68M | 13.58M | 13.13M | 12.99M | 12.89M | 12.79M | 12.29M | 12.06M | 11.97M | 11.68M | 11.47M | 11.42M | 11.12M | 10.34M | 9.87M |
| Basic Shares Outstanding | 15.64M | 15.47M | 15.39M | 15.31M | 15.41M | 15.35M | 15.31M | 15.27M | 15.22M | 15.19M | 15.13M | 13.89M | 13.82M | 13.83M | 13.85M | 13.77M | 13.67M | 13.56M | 12.83M | 12.56M | 12.29M | 12.24M | 11.69M | 11.61M | 11.51M | 11.27M | 11.45M | 11.42M | 11.12M | 8.87M | 8.42M |
| Dividend Payout Ratio | - | 32.25% | 36.27% | 53.24% | 154.17% | 23.11% | 76.24% | 45.75% | 50.59% | 50.24% | 51.04% | 39.68% | 35.05% | 27.04% | 52.02% | 24.55% | 28.05% | 33.73% | 31.74% | 21.49% | 22.07% | 23.47% | - | - | - | - | - | - | - | 56.76% | 59.73% |
Quick answers to the most common questions about buying NHC stock.
For fiscal year 2025, National HealthCare Corporation (NHC) reported total revenue of $1.52B. This represents a 292.9% increase compared to $386.3M in 1996.
National HealthCare Corporation (NHC) is profitable, generating $120.0M in net income for the fiscal year ending 2025 with a net profit margin of 7.9%.
National HealthCare Corporation (NHC) reported an operating income of $128.4M, resulting in an operating profit margin of 8.5%. This margin reflects the operational efficiency of the business before interest and taxes.
National HealthCare Corporation (NHC) generated $596.7M in gross profit for the year, representing a gross profit margin of 39.3%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Regulatory staffing mandate risk
Metrics are mathematically derived from official filings.
Revenue Momentum Accelerates on Census Recovery
NHC's revenue grew 8.8% YoY in 2026Q2, accelerating from 2.2% in 2026Q1, according to the latest quarterly report, suggesting sustained top-line momentum from occupancy gains and rate adjustments.
The sequential acceleration from 2.2% to 8.8% YoY growth indicates that the company is benefiting from both improved skilled mix and higher occupancy, as evidenced by the revenue step-up from $381.8M to $408.0M. This trend appears durable given the ongoing recovery in skilled nursing demand and the company's strategic expansion into behavioral health, which may provide additional growth avenues. However, investors should monitor whether this pace is sustainable as the base effects from prior-year disruptions fade.
Gross Margin Expansion Reflects Operating Discipline
Gross margin improved to 40.7% in 2026Q2, up from 38.4% a year earlier, as reported in the income statement, indicating effective cost management despite inflationary pressures on labor and supplies.
The 230 basis point year-over-year expansion in gross margin suggests that NHC is successfully passing through rate increases and optimizing its cost structure, likely through better labor utilization and a favorable payer mix. This margin resilience is notable given the industry-wide challenges of wage inflation and regulatory mandates. The company's owner-operator model, which insulates it from REIT rent escalators, appears to provide a structural cost advantage that supports margin stability.
Operating Leverage Amplifies Earnings Growth
Operating income surged 43.4% YoY in 2026Q2 to $48.9M, outpacing revenue growth of 8.8%, based on the latest financials, demonstrating significant operating leverage as fixed costs are spread over a larger revenue base.
The operating margin expanded from 9.1% in 2025Q2 to 12.0% in 2026Q2, a 290 basis point improvement, indicating that SG&A expenses are growing at a slower pace than revenue. This leverage is a direct result of high fixed costs in facility operations, where incremental revenue flows through to operating income at a higher rate. The company's ability to maintain SG&A at roughly $11.5M despite revenue growth suggests disciplined overhead management, which should continue to drive margin expansion if revenue growth persists.
Earnings Quality Boosted by Investment Gains
Net income of $40.3M in 2026Q2 includes significant non-operating gains from marketable securities, as per the financial statements, which may overstate core operating profitability and warrant adjustment for normalized earnings.
The net margin of 9.9% in 2026Q2 is higher than the operating margin of 12.0% would suggest, implying that non-operating income, likely from the company's investment portfolio, is contributing to net income. This is consistent with NHC's large holdings of marketable securities, which can create volatility in reported earnings. Analysts should strip out these investment gains to assess the underlying profitability of the healthcare operations, which appears to be improving but not as robust as the headline net income suggests.
Labor Costs Remain the Primary Margin Risk
COGS increased 6.9% YoY in 2026Q2, slightly below revenue growth, as reported in the income statement, but labor costs remain the most volatile expense line and could pressure margins if staffing mandates escalate.
The cost of goods sold, which includes facility-level labor and supplies, grew at a slower pace than revenue, indicating that management is effectively controlling direct costs. However, the proposed federal minimum staffing mandates for long-term care facilities could force NHC to increase nursing hours, potentially raising labor costs significantly. The company's reliance on agency staffing during labor shortages has historically caused margin compression, and any regulatory changes that exacerbate this could undermine the current margin stability.
2024Q4 Marked a Turning Point in Margin Recovery
The 2024Q4 quarter showed a sharp improvement in gross margin to 36.6% from 38.2% in 2024Q2, as per the income statement, signaling the start of a margin recovery driven by operational efficiencies and revenue growth.
In 2024Q4, revenue jumped 22.7% YoY to $369.4M, and gross margin expanded to 36.6%, up from 36.6% in the prior year, but more importantly, operating income rose to $26.6M from $15.6M in 2024Q1, indicating a step-change in profitability. This inflection appears to be driven by improved occupancy and skilled mix, as well as cost containment measures. The subsequent quarters have built on this momentum, with gross margins consistently above 39%, suggesting that the operational improvements are sustainable.
What Could Invalidate the Base Case
Despite strong recent growth, NHC's reliance on investment gains and potential regulatory staffing mandates could compress margins, as reported in the latest financials, challenging the sustainability of earnings growth.
The elevated net income in 2026Q2 may be overstated by non-operating investment gains, which are not core to healthcare operations and could reverse. Additionally, the proposed federal minimum staffing mandates could force significant labor cost increases, directly pressuring the gross margin that has been a key driver of the bull case. If occupancy gains plateau or skilled mix deteriorates, the operating leverage that amplified earnings could reverse, leading to margin compression and slower EPS growth.